Archive · 18 Aug 2025
Indian Drugmakers Seek to Boost Exports to Mexico
Indian drug companies want to sell more medicine to Mexico, the second-biggest market in South America.
They're talking to Mexican officials to make it easier to get their drugs approved.
Right now, it's hard and takes a long time.
Mexico's market is worth a lot of money and is growing.
If things go well, Indian companies could sell a lot more medicine there and maybe even use Mexico to sell to other nearby countries like the United States.
It's all part of a bigger plan to increase trade between India and Mexico.
Indian drugmakers are in talks with Mexico to simplify drug approval processes.
The Indian Drugs Manufacturers Association (IDMA) is focusing on boosting medicine exports to Mexico.
Mexico's pharmaceutical market is the second largest in Latin America and is valued at over $20 billion.
Indian pharmaceutical exports to Mexico are currently only $180 million.
Indian companies aim to use Mexico as a base to expand into North and Central American markets.
- Who
- Indian drug manufacturers and IDMA.
- What
- Indian drugmakers are seeking to boost exports to Mexico.
- When
- Ongoing discussions.
- Where
- Mexico.
- Why
- To increase exports and leverage Mexico's market and trade agreements.
Indian Drugmakers' Perspective
Mexican Regulatory Perspective
Regulatory Hurdles
Indian Drugmakers' Perspective
Simplified approval process
Mexican Regulatory Perspective
Complex approval process
- Mexico's Pharma Market Value
- Over $20 billion
- Expected Market Growth by 2033
- $38.5 billion
- Current Indian Pharma Exports to Mexico
- $180 million
- India's Pharma Market (FY2023-24)
- $50 billion
- India's Pharma Exports (FY2023-24)
- $26.5 billion